Comment from Allucent Government Services, (US) LLC

Summary: Allucent (US) LLC, a global contract research organization, supports the FDA's proposed Expedited Investigational New Drug (IND) Pilot Program (Operation TrialBlazer). They provide specific recommendations to ensure the pilot effectively shortens the timeline to first-in-human initiation through objective QRI qualification, modular tracks, and clear success metrics while maintaining safety standards.